ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

Carmona’s Term as Surgeon General Expires.

August 4, 2006

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

KnowMed Buys CancerSource.com Subsidiary Of Jones & Bartlet Publishers.

December 1, 2000

Funding opportunities listed.

July 16, 2004

DFCI Puts The Cancer Letter On Its Intranet For Employees.

February 11, 2000